Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. The 39th Annual Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow® will provide evidence-based, state-of-the-art cancer care for routine cases and the most challenging clinical scenarios. Gain in-depth updates on hematologic malignancies from world-renowned experts across a variety of tumor types.
This extensive conference features 100 experts across 25 tumor types, making this the perfect educational venue for everyone.
This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other health care professionals interested in the treatment of cancer are also invited to attend.
Use code CFS35 for 35% off registration.
Date and Time:
November 3-5, 2021 - Eastern Time
New York Marriott Marquis
New York, NY 10036
*Also virtual option
Ajai Chari, MD
Professor of Medicine, Hematology and Medical Oncology
Director of Clinical Research, Multiple Myeloma Program
Associate Director of Clinical Research, Mount Sinai Cancer Clinical Trials Office,
Icahn School of Medicine at Mount Sinai
New York, NY
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center,
Sibley Memorial Hospital
Tiffany A. Traina, MD
Associate Attending Physician, Vice Chair, Oncology (Manhattan) Department of Medicine
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY